Treatment of Anxiety and Sleep Disorders in Children

Safety Concerns and Adverse Effects

The American Academy of Child and Adolescent Psychiatry notes that SSRIs, including sertraline, have empirical support for anxiety treatment in children, but should be used with careful monitoring for adverse effects such as behavioral activation/agitation, gastrointestinal symptoms, and sleep disturbances 1
Approximately 7% of children experienced clinically important weight loss (>7% of body weight) in clinical trials, highlighting the need for close monitoring of weight changes 1

For anxiety in children, cognitive-behavioral therapy (CBT) is recommended as first-line treatment, with medication considered for more severe presentations 4
The American Academy of Child and Adolescent Psychiatry recommends SSRIs, including sertraline, as treatment options for anxiety in children, but only after appropriate diagnosis and as part of a comprehensive treatment plan 2, 3

Melatonin has been shown to be effective for sleep disorders in children, with a better safety profile than prescription medications, and has demonstrated significant improvements in sleep latency and duration 5
Benzodiazepines and antihistamines should be approached cautiously for sleep in children due to potential side effects, including disinhibition 2, 5

For an 8-year-old with anxiety, the American Academy of Child and Adolescent Psychiatry recommends beginning with cognitive-behavioral therapy as first-line treatment, and considering medication only if necessary, with close monitoring for adverse effects 4
If an SSRI is prescribed off-label for anxiety, it is recommended to start with a subtherapeutic "test" dose and monitor closely for adverse effects, particularly suicidal thinking and behavior, weight changes, and behavioral activation/agitation 1, 6